S
Ecosystem Profile
Syantra
A startup that develops diagnostic platforms using biomarkers and gene expression patterns to detect cancer.
Canadian Venture (AB)1
Dispatches
Apr 15, 2026
Last Signal
Full Coverage Archive
Beyond the Mammogram: How Syantra's Bio-Marker Approach is Redefining Early Cancer Detection in Canada
Beyond the Mammogram: How Syantra's Bio-Marker Approach is Redefining Early Cancer Detection in Canada
From the outset, Bob Shepherd and the team at Syantra have approached diagnostic science with a crucial pivot: not just improving existing technology, but fundamentally changing the detection paradigm. Their v...
↗ Syantra's Onco-ID represents a critical shift from structural diagnosis to functional biology. By mapping immune response patterns via gene expression biomarkers, the test promises to overcome key limitations of mammography (like high breast density) and potentially catch cancer far earlier, positioning itself as a highly sophisticated, single-disease focused, liquid biopsy platform.